Insider Transactions


Tricida, Inc.

Pages

Tricida, Inc.

$TCDA

Search Table
Pages

Trade Date Insider Title Buy or Sell Quantity Security Type Price Proceeds Transaction Conviction Position Quantity Position Value Positon Conviction SEC Link Nature of Ownership
2020-07-01Gerrit KlaernerPresident and CEOSell4,000Common Stock$27.15$108,600.00  -547,321$14,859,765.15  -Form 4-
2020-04-06Gerrit KlaernerPresident and CEOSell4,000Common Stock$24.22$96,880.00  0.80     [ High ]559,321$13,546,754.62  111.97   [Very High]Form 4-
2020-04-15Gerrit KlaernerPresident and CEOSell3,900Common Stock$27.46$107,094.00  0.78     [ High ]37,423$1,027,635.58  7.49     [Average]Form 4By Spouse
2020-04-15Gerrit KlaernerPresident and CEOSell100Common Stock$27.97$2,797.00  0.02     [ Very Low ]37,323$1,043,924.31  7.47     [Average]Form 4By Spouse
2020-04-28Dawn Parsell OttoEVP, Clinical DevelopmentBuy1,250Common Stock$1.68-$2,100.00  0.25     [ Low ]1,505$2,528.40  0.30     [Very Low]Form 4-
2020-04-28Dawn Parsell OttoEVP, Clinical DevelopmentSell1,250Common Stock$29.98$37,475.00  0.25     [ Low ]255$7,644.90  0.05     [Very Low]Form 4-
2020-04-29Dawn Parsell OttoEVP, Clinical DevelopmentBuy210Common Stock$1.68-$352.80  0.04     [ Very Low ]465$781.20  0.09     [Very Low]Form 4-
2020-04-29Dawn Parsell OttoEVP, Clinical DevelopmentSell210Common Stock$31.98$6,715.80  0.04     [ Very Low ]255$8,154.90  0.05     [Very Low]Form 4-
2020-04-29Dawn Parsell OttoEVP, Clinical DevelopmentBuy1,744Common Stock$1.68-$2,929.92  0.35     [ Average ]1,999$3,358.32  0.40     [Very Low]Form 4-
2020-04-29Dawn Parsell OttoEVP, Clinical DevelopmentSell1,744Common Stock$31.98$55,773.12  0.35     [ Average ]255$8,154.90  0.05     [Very Low]Form 4-
2020-04-29Dawn Parsell OttoEVP, Clinical DevelopmentBuy523Common Stock$2.39-$1,249.97  0.10     [ Low ]778$1,859.42  0.16     [Very Low]Form 4-
2020-04-29Dawn Parsell OttoEVP, Clinical DevelopmentSell523Common Stock$31.98$16,725.54  0.10     [ Low ]255$8,154.90  0.05     [Very Low]Form 4-
2020-04-29Dawn Parsell OttoEVP, Clinical DevelopmentBuy523Common Stock$7.49-$3,917.27  0.10     [ Low ]778$5,827.22  0.16     [Very Low]Form 4-
2020-04-29Dawn Parsell OttoEVP, Clinical DevelopmentSell523Common Stock$31.98$16,725.54  0.10     [ Low ]255$8,154.90  0.05     [Very Low]Form 4-
2020-05-01Gerrit KlaernerPresident and CEOSell3,050Common Stock$27.68$84,424.00  0.61     [ Average ]556,271$15,397,581.28  111.36   [Very High]Form 4-
2020-05-01Gerrit KlaernerPresident and CEOSell850Common Stock$28.86$24,531.00  0.17     [ Low ]555,421$16,029,450.06  111.19   [Very High]Form 4-
2020-05-01Gerrit KlaernerPresident and CEOSell100Common Stock$29.51$2,951.00  0.02     [ Very Low ]555,321$16,387,522.71  111.17   [Very High]Form 4-
2020-05-15Gerrit KlaernerPresident and CEOSell2,000Common Stock$31.24$62,480.00  0.40     [ Average ]35,323$1,103,490.52  7.07     [Average]Form 4By Spouse
2020-05-15Gerrit KlaernerPresident and CEOSell2,000Common Stock$31.87$63,740.00  0.40     [ Average ]33,323$1,062,004.01  6.67     [Average]Form 4By Spouse
2020-05-05Dawn Parsell OttoEVP, Clinical DevelopmentBuy798Common Stock$1.68-$1,340.64  0.16     [ Low ]1,053$1,769.04  0.21     [Very Low]Form 4-
2020-05-05Dawn Parsell OttoEVP, Clinical DevelopmentSell798Common Stock$30.05$23,979.90  0.16     [ Low ]255$7,662.75  0.05     [Very Low]Form 4-
2020-05-05Dawn Parsell OttoEVP, Clinical DevelopmentBuy452Common Stock$2.39-$1,080.28  0.09     [ Low ]707$1,689.73  0.14     [Very Low]Form 4-
2020-05-05Dawn Parsell OttoEVP, Clinical DevelopmentSell452Common Stock$30.31$13,700.12  0.09     [ Low ]255$7,729.05  0.05     [Very Low]Form 4-
2020-05-11Geoffrey M. ParkerChief Fin. Officer and EVPBuy12,404Common Stock$29.48-$365,669.92  2.48     [ Very High ]72,404$2,134,469.92  14.49    [Average]Form 4By Geoffrey M. Parker and Jill Gofen Parker Rev. Trust dated 1/27/00
2020-05-11Geoffrey M. ParkerChief Fin. Officer and EVPBuy19,854Common Stock$30.36-$602,767.44  3.97     [ Very High ]92,258$2,800,952.88  18.47    [High]Form 4By Geoffrey M. Parker and Jill Gofen Parker Rev. Trust dated 1/27/00
2020-05-12Geoffrey M. ParkerChief Fin. Officer and EVPBuy1,303Common Stock$30.09-$39,207.27  0.26     [ Low ]93,561$2,815,250.49  18.73    [High]Form 4By Geoffrey M. Parker and Jill Gofen Parker Rev. Trust dated 1/27/00
2020-05-12Geoffrey M. ParkerChief Fin. Officer and EVPBuy1,439Common Stock$31.66-$45,558.74  0.29     [ Average ]95,000$3,007,700.00  19.02    [High]Form 4By Geoffrey M. Parker and Jill Gofen Parker Rev. Trust dated 1/27/00
2020-05-08Dawn Parsell OttoEVP, Clinical DevelopmentBuy210Common Stock$1.68-$352.80  0.04     [ Very Low ]465$781.20  0.09     [Very Low]Form 4-
2020-05-08Dawn Parsell OttoEVP, Clinical DevelopmentSell210Common Stock$31.98$6,715.80  0.04     [ Very Low ]255$8,154.90  0.05     [Very Low]Form 4-
2020-05-08Dawn Parsell OttoEVP, Clinical DevelopmentBuy830Common Stock$1.68-$1,394.40  0.17     [ Low ]1,085$1,822.80  0.22     [Very Low]Form 4-
2020-05-08Dawn Parsell OttoEVP, Clinical DevelopmentSell830Common Stock$31.98$26,543.40  0.17     [ Low ]255$8,154.90  0.05     [Very Low]Form 4-
2020-05-08Dawn Parsell OttoEVP, Clinical DevelopmentBuy523Common Stock$7.49-$3,917.27  0.10     [ Low ]778$5,827.22  0.16     [Very Low]Form 4-
2020-05-08Dawn Parsell OttoEVP, Clinical DevelopmentSell523Common Stock$31.98$16,725.54  0.10     [ Low ]255$8,154.90  0.05     [Very Low]Form 4-
2020-05-08Dawn Parsell OttoEVP, Clinical DevelopmentBuy1,437Common Stock$2.39-$3,434.43  0.29     [ Average ]1,692$4,043.88  0.34     [Very Low]Form 4-
2020-05-08Dawn Parsell OttoEVP, Clinical DevelopmentSell1,437Common Stock$31.98$45,955.26  0.29     [ Average ]255$8,154.90  0.05     [Very Low]Form 4-
2020-06-01Gerrit KlaernerPresident and CEOSell4,000Common Stock$26.23$104,920.00  -551,321$14,461,149.83  -Form 4-
2020-06-11Kathryn E Falberg-Buy5,670Common Stock$0.00$0.00  -42,760$0.00  8.56     [Average]Form 4-
2020-06-11Veitinger Klaus R Dr-Buy5,670Common Stock$0.00$0.00  -46,985$0.00  9.41     [Average]Form 4-
2020-06-11Robert J Alpern-Buy5,670Common Stock$0.00$0.00  -143,060$0.00  28.64    [High]Form 4-
2020-06-11David P Bonita-Buy5,670Common Stock$0.00$0.00  -11,181$0.00  2.24     [Low]Form 4By David P. Bonita
2020-06-11Sandra I Coufal-Buy5,670Common Stock$0.00$0.00  -222,609$0.00  44.56    [High]Form 4-
2020-06-11David Hirsch-Buy5,670Common Stock$0.00$0.00  -11,181$0.00  2.24     [Low]Form 4-
2020-06-15Gerrit KlaernerPresident and CEOSell2,100Common Stock$26.20$55,020.00  -29,323$768,262.60  -Form 4By Spouse
2020-06-15Gerrit KlaernerPresident and CEOSell1,900Common Stock$25.71$48,849.00  -31,423$807,885.33  -Form 4By Spouse
2020-07-15Gerrit KlaernerPresident and CEOSell4,000Common Stock$26.33$105,320.00  0.80     [ High ]25,323$666,754.59  5.07     [Average]Form 4By Spouse
2020-09-10Geoffrey M. ParkerChief Fin. Officer and EVPBuy4,000Common Stock$0.00$0.00  -60,837$0.00  12.16    [Average]Form 4-
2020-09-10Wilhelm StahlEVP, Chief Tech OfficerBuy4,000Common Stock$0.00$0.00  -19,478$0.00  3.89     [Low]Form 4-
2020-09-10Gerrit KlaernerPresident and CEOBuy8,000Common Stock$0.00$0.00  -555,993$0.00  111.09   [Very High]Form 4-
2020-09-10Robert MckagueEVP, General CounselBuy4,000Common Stock$0.00$0.00  -4,000$0.00  0.80     [Very Low]Form 4-
2020-09-10Susannah CantrellEVP, Chief Comm. OfficerBuy4,000Common Stock$0.00$0.00  -4,000$0.00  0.80     [Very Low]Form 4-
2020-09-10Marc CoboSVP, Finance & CAOBuy3,000Common Stock$0.00$0.00  -3,000$0.00  0.60     [Very Low]Form 4-
2020-09-10Dawn Parsell OttoEVP, Clinical DevelopmentBuy4,000Common Stock$0.00$0.00  -4,637$0.00  0.93     [Very Low]Form 4-
2020-12-10Geoffrey M. ParkerCFO and EVPBuy15,000Common Stock$6.78-$101,700.00  2.99     [ Very High ]40,000$271,200.00  7.97     [Average]Form 4By Equity Trust Company, Trustee of the Geoffrey M. Parker Roth IRA
2020-12-11Robert MckagueEVP, General CounselBuy10,000Common Stock$7.62-$76,200.00  1.99     [ High ]10,000$76,200.00  1.99     [Low]Form 4The Robert McKague Living Trust dated July 31, 2019
2021-01-11Gerrit KlaernerPresident and CEOSell21,489Common Stock$7.49$160,952.61  4.28     [ Very High ]534,504$4,003,434.96  106.51   [Very High]Form 4-
2021-01-12Gerrit KlaernerPresident and CEOSell9,821Common Stock$7.65$75,130.65  1.96     [ High ]524,683$4,013,824.95  104.55   [Very High]Form 4-
2021-01-13Gerrit KlaernerPresident and CEOSell15,035Common Stock$7.41$111,409.35  3.00     [ Very High ]509,648$3,776,491.68  101.55   [Very High]Form 4-
2021-01-14Gerrit KlaernerPresident and CEOSell1,655Common Stock$7.18$11,882.90  0.33     [ Average ]507,993$3,647,389.74  101.22   [Very High]Form 4-